Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%
11 mai 2023 09h00 HE
|
Sunshine Biopharma Inc.
MONTREAL, May 11, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas...
Epirubicin Market Worth $243.99 Million, Globally, by 2028 at 3.6% CAGR - Exclusive Report by The Insight Partners
22 juil. 2022 06h56 HE
|
The Insight Partners
New York, July 22, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Epirubicin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Dosage (10mg/Vial,...